ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,787 | -27.7% | 66,518 | -4.0% | 0.02% | -25.0% |
Q2 2023 | $2,470 | +35.6% | 69,255 | -3.4% | 0.02% | +25.0% |
Q1 2023 | $1,821 | -39.6% | 71,700 | -3.6% | 0.02% | -40.7% |
Q4 2022 | $3,017 | -99.9% | 74,388 | +1.8% | 0.03% | +17.4% |
Q3 2022 | $2,415,000 | -3.9% | 73,081 | +2.4% | 0.02% | 0.0% |
Q2 2022 | $2,512,000 | -23.1% | 71,357 | +0.5% | 0.02% | -8.0% |
Q1 2022 | $3,266,000 | -66.6% | 71,009 | -51.9% | 0.02% | -30.6% |
Q4 2021 | $9,780,000 | +113.2% | 147,506 | +100.8% | 0.04% | -7.7% |
Q3 2021 | $4,587,000 | -31.8% | 73,469 | -9.5% | 0.04% | -27.8% |
Q2 2021 | $6,722,000 | +555.2% | 81,165 | +424.8% | 0.05% | +42.1% |
Q1 2021 | $1,026,000 | -19.4% | 15,466 | -6.7% | 0.04% | -20.8% |
Q4 2020 | $1,273,000 | +80.1% | 16,585 | +1.0% | 0.05% | +54.8% |
Q3 2020 | $707,000 | -3.5% | 16,425 | -3.2% | 0.03% | -8.8% |
Q2 2020 | $733,000 | +39.9% | 16,965 | -6.9% | 0.03% | +161.5% |
Q1 2020 | $524,000 | -54.0% | 18,218 | +1.5% | 0.01% | -38.1% |
Q4 2019 | $1,138,000 | +132.2% | 17,944 | +3.1% | 0.02% | +110.0% |
Q3 2019 | $490,000 | +4.7% | 17,404 | -1.5% | 0.01% | -9.1% |
Q2 2019 | $468,000 | +89.5% | 17,672 | +31.4% | 0.01% | +83.3% |
Q1 2019 | $247,000 | +55.3% | 13,444 | +5.0% | 0.01% | +20.0% |
Q4 2018 | $159,000 | -12.2% | 12,804 | -3.6% | 0.01% | +25.0% |
Q2 2018 | $181,000 | – | 13,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |